Prevention and Management of Bleeding Episodes in Children with Hemophilia

Regular prophylactic treatment with factor VIII (FVIII) and factor IX (FIX) concentrates in hemophilia A and B, respectively, is introduced in early infancy and has resulted in dramatic improvement of the conditions. Recombinant FVIII and FIX concentrates have been available for > 25 years and ha...

Descripción completa

Detalles Bibliográficos
Autor principal: Ljung, Rolf C. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153959/
https://www.ncbi.nlm.nih.gov/pubmed/30128815
http://dx.doi.org/10.1007/s40272-018-0307-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153959/
https://www.ncbi.nlm.nih.gov/pubmed/30128815
http://dx.doi.org/10.1007/s40272-018-0307-z

Ejemplares similares